|
|
||||
|
Stem cell research climate
Email: Eugene Russo - erusso@the-scientist.com News from The Scientist 2003, 4(1):20030627-02
|
||||
|
|
||||
|
WASHINGTON, D.C.—The legislative deadlock in Congress and explicit regulations from the Food and Drug Administration (FDA) make the United States a viable and, in some cases, preferable place to do stem cell and "therapeutic" cloning research, according to speakers at this week's Biotechnology Industry Organization (BIO) conference. Still, some US scientists seeking to do such research continue to look overseas.
|
|
|||||||||
|
|||||||||
|